insights_auto
Nega BOT tushdi 20,00%?
Batafsil oʻrganishchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080 A$
arrow_downward
-20,00%(-0,0020) 1K
20-noy, 16:10:07 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
22,10 mln
Oʻrtacha hajm
11,07 mln
Hajmi
8,60 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
22,10 mln
Oʻrtacha hajm
11,07 mln
Hajmi
8,60 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Adam Feldman | Substack
·
13 soat oldin
Inside the Federal Litigation of Five S&P 500 Giants
The Harvard Law School Forum on Corporate Governance
·
19 soat oldin
Board Practices and Composition in the Russell 3000 and S&P 500
The Motley Fool
·
8 soat oldin
The Semiconductor ETF Is on Track to Beat the S&P 500 for a 4th Straight Year. It Has Never Done That Before.
24/7 Wall St.
·
19 soat oldin
4 S&P 500 Dividend Stocks Paying Shareholders More Than Their Free Cash Flow
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida